ArticleHypertension research : official journal of the Japanese Society of Hypertension2026
Effects of sodium reduction interventions on home and morning home blood pressure: a systematic review and meta-analysis of randomized controlled trials.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Excessive sodium chloride (salt) intake significantly contributes to hypertension and cardiovascular diseases, and reducing sodium is a cornerstone of non-pharmacological management of hypertension. Although the antihypertensive effects of sodium reduction are well established, most existing evidence is from office blood pressure (BP) measurements, with limited data available on home BP. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the effects of sodium reduction on home BP. We searched PubMed and the Cochrane Library from inception to September 2025 and included 23 RCTs comprising 4110 participants. Sodium reduction significantly reduced home systolic BP (SBP) (mean difference [MD], -3.66 mmHg; 95% confidence interval [CI], -4.86 to -2.45; P < 0.001) and home diastolic BP (MD, -1.40 mmHg; 95% CI, -2.08 to -0.71; P < 0.001). Nine studies that reported morning home BP also showed reduced morning home SBP (MD, -4.06 mmHg; 95% CI, -6.60 to -1.52; P = 0.002). Greater reductions in home SBP were observed in predominantly hypertensive populations than in non-hypertensive populations (P for heterogeneity = 0.003). No significant differences were detected across other predefined subgroups. Sodium reduction interventions were also associated with significant reductions in salt intake, urinary sodium excretion, and the urinary sodium-to-potassium ratio. Quantitative synthesis was not feasible because only a few included studies reported cardiovascular or adverse events. In conclusion, sodium reduction interventions effectively lower home BP, including morning home BP, with a greater impact in hypertensive populations. Thus, reducing sodium is a practical strategy for improving home BP control, particularly in hypertensive populations. This systematic review and meta-analysis of randomized controlled trials showed that sodium reduction interventions significantly lowered home systolic blood pressure (SBP), including morning SBP. No significant differences in BP-lowering effects were detected across various sodium reduction strategies, and digital health approaches may support implementation and adherence. Sodium reduction interventions were also associated with reductions in salt intake, urinary sodium excretion, and the urinary sodium-to-potassium ratio. These findings support major hypertension guidelines, including the Japanese Society of Hypertension Guidelines for managing elevated blood pressure and hypertension 2025 (JSH2025) and the JSH Morning Hypertension Eradication Program Project (Asakatsu BP Action Plan-the Morning Blood Pressure 130 Campaign).
Indexed as
Identifiers
42716956What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.